PRINCETON, NJ—Feinstein Kean Healthcare, the Ogilvy Public Relations subsidiary best known for its work in the biotechnology industry, is opening a new office in Princeton to service major pharmaceutical clients including Johnson & Johnson, Merck, Novartis and Pfizer.
The new office will be led by senior vice presidents Beth Kramli, who joins Feinstein from parent company Ogilvy, and Michael Lampe, who has served on the leadership team in FKH’s Cambridge, Mass., headquarters for the past three years.
“FKH has cultivated relationships with many of the leading life-sciences companies located in the New Jersey region,” said Marcia Kean, chief executive officer. “The expansion into New Jersey is part of this firm’s ongoing commitment to offering our clients access to the best talent and to providing customized solutions to meet our clients’ needs.”
Kramli has more than 15 years experience in healthcare PR, with emphasis on cardiovascular disease, men’s health and respiratory illness. Lampe, who joined FKH in 2001, has been promoted to senior vice president in the FKH pharmaceutical practice.